Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy
Angewandte Chemie International Edition · 22.05.2023 · 62 (22)
DOI: 10.1002/anie.202301074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 19.04.2023. Verfasst von Ganghao Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences,…. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Verband der Chemischen Industrie.
Abstract (Originalsprache)
The development of Pt IV prodrugs that are reduced into the therapeutically active Pt II species within the tumor microenvironment has received much research interest. In order to provide spatial and temporal control over the treatment, there is a high demand for the development of compounds that could be selectively activated upon irradiation. Despite recent progress, the majority of Pt IV complexes are excited with ultraviolet or blue light, limiting the use of such compounds to superficial application. To overcome this limitation, herein, the first example of Pt IV prodrug nanoparticles that could be reduced with deeply penetrating ultrasound radiation is reported, enabling the treatment of deep‐seated or large tumors. The nanoparticles were found to selectively accumulate inside a mouse colon carcinoma tumor upon intravenous injection and were able to eradicate the tumor upon exposure to ultrasound radiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
- Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India.
- Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.
ORCID-Profile: Johannes Karges
Förderung
- National Natural Science Foundation of China
- Verband der Chemischen Industrie
Zitieren
APA
Liang, G., Sadhukhan, T., Banerjee, S., Tang, D., Zhang, H., Cui, M., Montesdeoca, N., Karges, J., & Xiao, H. (2023). Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy. Angewandte Chemie International Edition, 62(22). https://doi.org/10.1002/anie.202301074
Vancouver
Liang G, Sadhukhan T, Banerjee S, Tang D, Zhang H, Cui M, et al. Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy. Angewandte Chemie International Edition. 2023;62(22). doi:10.1002/anie.202301074
BibTeX
@article{Liang2023,
author = {Liang, Ganghao and Sadhukhan, Tumpa and Banerjee, Samya and Tang, Dongsheng and Zhang, Hanchen and Cui, Minhui and Montesdeoca, Nicolás and Karges, Johannes and Xiao, Haihua},
title = {Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {22},
doi = {10.1002/anie.202301074}
}
EUVIMED